Velcade (bortezomib)

Velcade (bortezomib) is a medication used to treat certain blood cancers, such as multiple myeloma and mantle cell lymphoma. It works by blocking a protein-degrading system inside cells called the proteasome, which helps cancer cells grow and survive. By inhibiting this system, Velcade causes cancer cells to accumulate damaged proteins, leading to their death. It is administered via injection and is typically used in combination with other therapies to improve treatment outcomes. Velcade helps control the disease, potentially reducing symptoms and improving quality of life for patients with these types of cancers.